(University of Alberta) A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2GEOCIH
No comments:
Post a Comment